
About Azelnidipine
Azelnidipine is a Healthcare company based in Ankleshwar (India) founded in 2016. It produces high-quality APIs and pharmaceutical intermediates for the industry. It operates on a B2B model. The company has 58 employees. Its Indian entity Pure Chem Pvt Ltd reported revenue of βΉ36.10 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Azelnidipine, established in 2016, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and intermediates. Produces high-quality APIs and pharmaceutical intermediates for the industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Ankleshwar, India
- Employees 58
- SectorsHealthcare
- Website azelnidipine.in
- Legal Name Pure Chem Pvt. Ltd
- Date of Incorporation 07 Apr, 1995
- Jurisdiction Ankleshwar, Gujarat, India
- Annual Revenue₹36.10 Cr
FY 2025 · -9% YoY
- Net Profit₹2.62 Cr
FY 2025 · 7% margin
- EBITDA₹4.85 Cr
FY 2025 · 13% margin
- Employee Count58
Associated legal entities of Azelnidipine
Azelnidipine operates through Pure Chem Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pure Chem Pvt Ltd CIN U24119GJ1995PTC025431 | Active | 07 Apr 1995 | Ankleshwar, Gujarat | ₹36.1 Cr | 58 | 2 | View details |
Board of directors of Pure Chem Pvt Ltd (Azelnidipine)
Pure Chem Pvt Ltd is the primary company behind Azelnidipine. The board of Pure Chem Pvt Ltd currently have 2 directors; the longest-serving is Rohitkumar Bhagwanbhai Dholakia, appointed in 2013. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rohitkumar Bhagwanbhai Dholakia DIN 06502093 | Director | 18 Feb 2013 | 13 yrs 9 mo | Pure Chem Pvt Ltd |
| Hareshkumar Nanjibhai Lathiya DIN 06502103 | Director | 18 Mar 2013 | 13 yrs 8 mo | Pure Chem Pvt Ltd |
Financials of Azelnidipine
Figures of Pure Chem Pvt Ltd, the primary company behind Azelnidipine, for FY 2025. Revenue was ₹36.10 Cr (-9% year on year). Net profit was ₹2.62 Cr (7% margin). EBITDA was ₹4.85 Cr (13% margin). Revenue has grown at a compounded annual rate of +3% over three years and 0% over five years.
- ₹36.10 CrRevenue · FY 2025 · -9% YoY
- ₹2.62 CrNet profit · 7% margin
- ₹4.85 CrEBITDA · 13% margin
- ₹2.00 CrPaid-up capital
- 58Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pure Chem Pvt Ltd are on its company page.
Detailed financial statements for Azelnidipine
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Azelnidipine
Azelnidipine has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Azelnidipine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Azelnidipine
Azelnidipine was founded in 2016.
Azelnidipine is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.
Azelnidipine has 58 employees.
The primary company behind Azelnidipine, Pure Chem Pvt Ltd, reported revenue of βΉ36.10 Cr for FY 2025, down 9% year on year.
Azelnidipine, established in 2016, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and intermediates. Produces high-quality APIs and pharmaceutical intermediates for the industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Azelnidipine's top competitors include Laurus Labs, Symbiotec and SeQuent.
Azelnidipine operates through Pure Chem Pvt Ltd.
The legal entities of Azelnidipine currently have 2 directors, including Rohitkumar Bhagwanbhai Dholakia, Hareshkumar Nanjibhai Lathiya.